The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
Open accessAbstract
Although metformin is widely used for the treatment of non-insulin-dependent diabetes, its mode of action remains unclear. Here we provide evidence that its primary site of action is through a direct inhibition of complex 1 of the respiratory chain. Metformin (50 μM) inhibited mitochondrial oxidation of glutamate+malate in hepatoma cells by 13 and 30% after 24 and 60 h exposure respectively, but succinate oxidation was unaffected. Metformin also caused time-dependent inhibition of complex 1 in isolated mitochondria, whereas in sub-mitochondrial particles inhibition was immediate but required very high metformin concentrations (K0.5, 79 mM). These data are compatible with the slow membrane-potential-driven accumulation of the positively charged drug within the mitochondrial matrix leading to inhibition of complex 1. Metformin inhibition of gluconeogenesis from L-lactate in isolated rat hepatocytes was also time- and concentration-dependent, and accompanied by changes in metabolite levels similar to those induced by other inhibitors of gluconeogenesis acting on complex 1. Freeze-clamped livers from metformin-treated rats exhibited similar changes in metabolite concentrations. We conclude that the drug's pharmacological effects are mediated, at least in part, through a time-dependent, self-limiting inhibition of the respiratory chain that restrains hepatic gluconeogenesis while increasing glucose utilization in peripheral tissues. Lactic acidosis, an occasional side effect, can also be explained in this way.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metformin may cause lactic acidosis through impairment of oxidative phosphorylation.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [464]
In the citing paper
“it has been shown to accumulate in mitochondria due to the membrane potential across the mitochondrial inner membrane”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Owen et al. 2000
In the citing paper
“However, metformin, one of the commonly prescribed drugs for treating type II diabetes, is safe despite acting as a mitochondrial complex I inhibitor that impairs respiration (Bridges et al., 2014; El-Mir et al., 2000; Owen et al., 2000; Wheaton et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Owen et al., 2000
In the citing paper
“This inhibition would in turn decrease the ATP/AMP ratio activating AMPK (127–129).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“As pointed out by Fontaine, a problem associated with accepting the argument that the therapeutic effects of metformin result from inhibition of complex 1, as depicted in Figure 1, are the high concentrations used in the cell culture studies described by El Mir et al. and Owen et al. (127, 128, 133).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [210]
Citations
Cites
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Ebert, B. L., Firth, J. D., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29083 · Cited by 569
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., & Klip, A. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505458 · Cited by 243
Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227
Argaud, D., Roth, H., Wiernsperger, N. F., & Leverve, X. M. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17886.x · Cited by 151
Biguanide-associated lactic acidosis. Case report and review of the literature
Gan, S. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.11.2333 · Cited by 129
Halestrap, A. P. (1987) · Biochemical Journal · doi:10.1042/bj2440159 · Cited by 120
Self-citationFischer, Y., Thomas, J., Rosen, P., & Kammermeier, H. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835271 · Cited by 114
Cited by
Sorted by citations
Items 601–700 of 1,008
Li, C., Zhang, C., Zhou, H., Feng, Y., Tang, F., Hoi, M. P. M., He, C., Ma, D., Zhao, C., & Lee, S. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00098 · Cited by 71
Lorenzo-Almorós, A., Cepeda-Rodrigo, J. M., & Lorenzo, Ó. (2020) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2019.10.012 · Cited by 74
Piel, S., Ehinger, J. K., Elmér, E., & Hansson, M. J. (2014) · Acta Physiologica · doi:10.1111/apha.12311 · Cited by 72
Gu, Y. J., Qi, C., Sun, X., Ma, X., Zhang, H., Hu, L., Yuan, J., & Yu, Q. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.06.002 · Cited by 71
Vara‐Ciruelos, D., Dandapani, M., Russell, F. M., Grzes, K. M., Atrih, A., Foretz, M., Viollet, B., Lamont, D. J., Cantrell, D. A., & Hardie, D. G. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.067 · Cited by 76
Estradiol effects on hypothalamic AMPK and BAT thermogenesis: A gateway for obesity treatment?
López, M., & Tena-Sempere, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.014 · Cited by 70
Old drug, new trick: Repurposing metformin for gynecologic cancers?
Febbraro, T., Lengyel, E. R., & Romero, I. L. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.10.011 · Cited by 71
Cortés‐Rojo, C., Vargas-Vargas, M. A., Olmos‐Orizaba, B. E., Rodríguez-Orozco, A. R., & Calderón‐Cortés, E. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165801 · Cited by 73
Understanding the action mechanisms of metformin in the gastrointestinal tract
Cheng, M., Ren, L., Jia, X., Wang, J., & Cong, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1347047 · Cited by 78
Woollhead, A. M., Scott, J. W., Hardie, D. G., & Baines, D. L. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.088674 · Cited by 70
An Update on the Pharmacogenomics of Metformin: Progress, Problems and Potential
Todd, J. N., & Florez, J. C. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.21 · Cited by 72
Metformin overdose causes platelet mitochondrial dysfunction in humans
Protti, A., Lecchi, A., Fortunato, F., Artoni, A., Greppi, N., Vecchio, S., Fagiolari, G., Moggio, M. G., Comi, G. P., Mistraletti, G., et al. (2012) · Critical Care · doi:10.1186/cc11663 · Cited by 71
Berberine suppresses gero-conversion from cell cycle arrest to senescence
Zhao, H., Halicka, H. D., Li, J., & Darżynkiewicz, Z. (2013) · Aging · doi:10.18632/aging.100593 · Cited by 71
Age-dependent effects in fathead minnows from the anti-diabetic drug metformin
Crago, J., Bui, C. V., Grewal, S., & Schlenk, D. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.12.030 · Cited by 70
Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
Curry, J., Johnson, J. M., Tassone, P. T., Domingo‐Vidal, M., Menezes, D. W., Sprandio, J. D., Mollaee, M., Cotzia, P., Birbe, R., Lin, Z., et al. (2017) · The Laryngoscope · doi:10.1002/lary.26489 · Cited by 72
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Florez, J. C. (2017) · Diabetologia · doi:10.1007/s00125-017-4227-1 · Cited by 71
Caldwell, D. J., D’Aco, V. J., Davidson, T., Kappler, K., Murray‐Smith, R., Owen, S. F., Robinson, P. F., Simon-Hettich, B., Straub, J. O., & Tell, J. G. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.10.038 · Cited by 72
AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases
Lu, Q., Li, X., Liu, J., Sun, X., Rousselle, T., Ren, D., Tong, N., & Li, J. (2019) · Bioscience Reports · doi:10.1042/bsr20181995 · Cited by 69
The Epidemiology and Molecular Mechanisms Linking Obesity, Diabetes, and Cancer
Ferguson, R. D., Gallagher, E. J., Scheinman, E. J., Damouni, R., & LeRoith, D. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-416673-8.00010-1 · Cited by 72
Current topics on inhibitors of respiratory complex I
Murai, M., & Miyoshi, H. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.11.009 · Cited by 73
Metformin: A Candidate Drug for Renal Diseases
Corremans, R., Vervaet, B. A., D’Haese, P. C., Neven, E., & Verhulst, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010042 · Cited by 71
AMP-activated protein kinase activator A-769662 is an inhibitor of the Na+-K+-ATPase
Benziane, B., Björnholm, M., Lantier, L., Viollet, B., Zierath, J. R., & Chibalin, A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00010.2009 · Cited by 73
Health benefits of late-onset metformin treatment every other week in mice
Alfaras, I., Mitchell, S. J., Mora, H., Lugo, D. R., Warren, A., Navas-Enamorado, I., Hoffmann, V., Hine, C., Mitchell, J. R., Le Couteur, D. G., et al. (2017) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-017-0018-7 · Cited by 68
Effect of metformin on stem cells: Molecular mechanism and clinical prospect
Jiang, L., & Liu, L. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i12.1455 · Cited by 69
The immunology of sepsis: translating new insights into clinical practice
Kox, M., Bauer, M. W., Bos, L. D. J., Bouma, H. R., Calandra, T., Calfee, C. S., Chousterman, B. G., Derde, L. P. G., Giamarellos‐Bourboulis, E. J., Gómez, H., et al. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01004-6 · Cited by 76
Deepa, S. S., Zhou, L., Ryu, J., Wang, C., Mao, X., Cai, L., Zhang, N., Musi, N., DeFronzo, R. A., Liu, F., et al. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0082 · Cited by 69
Revisiting the mechanisms of metformin action in the liver
Viollet, B., & Foretz, M. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2013.03.006 · Cited by 70
Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice
Mooney, M. H., Fogarty, S., Stevenson, C. L., Gallagher, A. M., Palit, P., Hawley, S. A., Hardie, D. G., Coxon, G. D., Waigh, R. D., Tate, R. J., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.37 · Cited by 68
Mitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67
Autophagy-nutrient sensing pathways in diabetic complications
Parmar, U. M., Jalgaonkar, M. P., Kulkarni, Y. A., & Oza, M. J. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106408 · Cited by 69
Tossetta, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112893 · Cited by 68
Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
Amengual-Cladera, E., Morla-Barcelo, P. M., Morán-Costoya, A., Valle, A., Pons, D. G., Sastre‐Serra, J., Roca, P., & Nadal‐Serrano, M. (2024) · Biology · doi:10.3390/biology13050302 · Cited by 74
Metformin raises hydrogen sulfide tissue concentrations in various mouse organs
Wiliński, B., Wiliński, J., Somogyi, E., Piotrowska, J., & Opoka, W. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71053-3 · Cited by 67
Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndrome
Harris, S. E., Maruthini, D., Tang, T., Balen, A. H., & Picton, H. M. (2010) · Human Reproduction · doi:10.1093/humrep/deq181 · Cited by 67
Kiaei, M. (2008) · PPAR Research · doi:10.1155/2008/418765 · Cited by 67
Hill, J. L., Kobori, N., Zhao, J., Rozas, N. S., Hylin, M. J., Moore, A. N., & Dash, P. K. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13726 · Cited by 67
Metformin Impairs Spatial Memory and Visual Acuity in Old Male Mice
Thangthaeng, N., Rutledge, M. A., Wong, J. M., Vann, P. H., Forster, M. J., & Sumien, N. (2017) · Aging and Disease · doi:10.14336/ad.2016.1010 · Cited by 69
Vlavcheski, F., Baron, D. C., Vlachogiannis, I. A., MacPherson, R. E. K., & Tsiani, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051321 · Cited by 68
Chaudhari, K., Wang, J., Xu, Y., Winters, A., Wang, L., Dong, X., Cheng, E. Y., Liu, R., & Yang, S.-H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234571 · Cited by 68
Qudus B Aroyehun, A., Abdul Razak, S., Palaniveloo, K., Nagappan, T., Suraiza Nabila Rahmah, N., Wee Jin, G., Chellappan, D. K., Chellian, J., & Kunnath, A. P. (2020) · Foods · doi:10.3390/foods9091313 · Cited by 66
Novel strategies for anti-aging drug discovery
Saraswat, K., & Rizvi, S. I. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1349750 · Cited by 66
Vujic, I., Sanlorenzo, M., Posch, C., Esteve‐Puig, R., Yen, A., Kwong, A., Tsumura, A., Murphy, R. M., Rappersberger, K., & Ortiz‐Urda, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2824 · Cited by 66
Goswami, S., Yee, S. W., STOCKER, S. L., Mosley, J. D., Kubo, M., Castro, R. A., Mefford, J., Wen, C., Liang, X., Witte, J. S., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.109 · Cited by 66
Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components
Bahar, E., Han, S., Kim, J., & Yoon, H. (2022) · Cancers · doi:10.3390/cancers14061462 · Cited by 67
Overview of metformin: special focus on metformin extended release
Ali, S., & Fonseca, V. A. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.705829 · Cited by 67
Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents
Sweeney, D., Raymer, M. L., & Lockwood, T. D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00338-1 · Cited by 66
Cardiovascular impact of drugs used in the treatment of diabetes
Triggle, C. R., & Ding, H. (2014) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622314546125 · Cited by 67
Pharmacogenetic studies update in type 2 diabetes mellitus
Singh, S. T., Usman, K., & Banerjee, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i15.302 · Cited by 67
Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease
Tayara, K., Espinosa‐Oliva, A. M., García-Domínguez, I., Ismaiel, A. A., Boza‐Serrano, A., Deierborg, T., Machado, A., Herrera, A. J., Venero, J. L., & de Pablos, R. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00440 · Cited by 66
Mitochondrial dynamics in exercise physiology
Tanaka, T., Nishimura, A., Nishiyama, K., Goto, T., Numaga‐Tomita, T., & Nishida, M. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02258-3 · Cited by 67
Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
Malaguarnera, R., Vella, V., Nicolosi, M. L., & Belfiore, A. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00314 · Cited by 68
AMPK signalling: Implications for podocyte biology in diabetic nephropathy
Szrejder, M., & Piwkowska, A. (2019) · Biology of the Cell · doi:10.1111/boc.201800077 · Cited by 65
The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells
Vial, G., Lamarche, F., Cottet‐Rousselle, C., Hallakou‐Bozec, S., Borel, A., & Fontaine, E. M. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.211 · Cited by 65
Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?
Hatoum, D., & McGowan, E. M. (2015) · BioMed Research International · doi:10.1155/2015/548436 · Cited by 67
Polycystic Kidney Disease and the Vasopressin Pathway
van Gastel, M. D. A., & Torres, V. E. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000463063 · Cited by 65
AMP-activated protein kinase: a therapeutic target in intestinal diseases
Sun, X., & Zhu, M. J. (2017) · Open Biology · doi:10.1098/rsob.170104 · Cited by 68
Hill, B. G., Shiva, S., Ballinger, S. W., Zhang, J., & Darley-Usmar, V. M. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0268 · Cited by 66
Mitochondrially-targeted treatment strategies
Bozi, L. H. M., Campos, J. C., Zambelli, V. O., Ferreira, N. D., & Ferreira, J. C. B. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100836 · Cited by 67
Metformin: A Prospective Alternative for the Treatment of Chronic Pain
Baeza‐Flores, G. D. C., Guzmán‐Priego, C. G., Flores, L. I. P., Murbartián, J., Torres‐López, J. E., & Granados‐Soto, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.558474 · Cited by 65
New Insights Into the Anti-Diabetic Actions of Metformin: From the Liver to the Gut
Wu, T., Horowitz, M., & Rayner, C. K. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1273769 · Cited by 64
Dietary Intervention Impacts Immune Cell Functions and Dynamics by Inducing Metabolic Rewiring
Okawa, T., Nagai, M., & Hase, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.623989 · Cited by 68
Cellular Senescence in Aging Lungs and Diseases
Aghali, A., Ngassie, M. L. K., Pabelick, C. M., & Prakash, Y. S. (2022) · Cells · doi:10.3390/cells11111781 · Cited by 67
Chen, Z., Zhang, L., Yi, J., Yang, Z., Zhang, Z., & Li, Z. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24232 · Cited by 64
Metformin overdose, but not lactic acidosis per se, inhibits oxygen consumption in pigs
Protti, A., Fortunato, F., Monti, M., Vecchio, S., Gatti, S., Comi, G. P., Giuseppe, R. D., & Gattinoni, L. (2012) · Critical Care · doi:10.1186/cc11332 · Cited by 64
Rozengurt, E. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00357 · Cited by 67
Granja, S., Marchiq, I., LeFloch, R., Moura, C. S., Baltazar, F., & Pouysségur, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2862 · Cited by 64
Choi, Y. W., & Lim, I. K. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.015 · Cited by 67
Partitioning of superoxide and hydrogen peroxide production by mitochondrial respiratory complex I
Grivennikova, V. G., & Vinogradov, A. D. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.01.002 · Cited by 64
Salomäki, H., Heinäniemi, M., Vähätalo, L. H., Ailanen, L., Eerola, K., Ruohonen, S. T., Pesonen, U., & Koulu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115778 · Cited by 63
Li, B., Po, S. S., Zhang, B., Bai, F., Li, J., Qin, F., Liu, N., Sun, C., Xiao, Y., Tu, T., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15407 · Cited by 63
Łabuzek, K., Liber, S., Gabryel, B., & Okopień, B. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70343-1 · Cited by 64
AMPK activators – potential therapeutics for metabolic and other diseases
Zhou, G., Sebhat, I. K., & Zhang, B. B. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01967.x · Cited by 63
Na, H., Park, J., Pyo, J.-H., Lee, S., Jeon, H.-J., Kim, Y.-S., & Yoo, M. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.07.003 · Cited by 63
Drahota, Z., Páleníčková, E., Endlicher, R., Milerová, M., Brejchová, J., Vošahlíková, M., Svoboda, P., Kazdova, L., Kalous, M., Červinková, Z., et al. (2014) · Physiological Research · doi:10.33549/physiolres.932600 · Cited by 64
Drug-Induced Mitochondrial Toxicity
Hargreaves, I. P., Shahrani, M. M. A., Wainwright, L., & Heales, S. (2016) · Drug Safety · doi:10.1007/s40264-016-0417-x · Cited by 63
Bizjak, M., Malavašič, P., Dolinar, K., Pohar, J., Pirkmajer, S., & Pavlin, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01801-5 · Cited by 66
Metformin as an adjuvant in breast cancer treatment
Roshan, M. H. K., Shing, Y. K., & Pace, N. P. (2019) · SAGE Open Medicine · doi:10.1177/2050312119865114 · Cited by 63
Jalali, M., Rahimlou, M., Mahmoodi, M., Moosavian, S. P., Symonds, M. E., Jalali, R., Zare, M., Imanieh, M. H., & Stasi, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104799 · Cited by 63
Rafeh, R. W., Viveiros, A., Oudit, G. Y., & EL‐Yazbi, A. F. (2020) · Clinical Science · doi:10.1042/cs20190227 · Cited by 63
Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin
Heishi, M., Ichihara, J., Teramoto, R., Itakura, Y., Hayashi, K., Ishikawa, H., Gomi, H., Sakai, J., Kanaoka, M., Taiji, M., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0271-y · Cited by 63
Altea-Manzano, P., Vandekeere, A., Edwards-Hicks, J., Roldan, M., Abraham, E., Lleshi, X., Guerrieri, A. N., Berardi, D., Wills, J., Junior, J. M., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.10.005 · Cited by 57
Steady-State Pharmacokinetics of Metformin Is Independent of the OCT1 Genotype in Healthy Volunteers
Christensen, M. M. H., Højlund, K., Hother-Nielsen, O., Stage, T. B., Damkier, P., Beck-Nielsen, H., & Brøsen, K. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1853-8 · Cited by 62
Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes
Hozumi, K., Sugawara, K., Ishihara, T., Ishihara, N., & Ogawa, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-27689-y · Cited by 62
Metformin targets mitochondrial complex I to lower blood glucose levels
Reczek, C. R., Chakrabarty, R. P., D’Alessandro, K. B., Sebo, Z. L., Grant, R. A., Gao, P., Budinger, G. R. S., & Chandel, N. S. (2024) · Science Advances · doi:10.1126/sciadv.ads5466 · Cited by 67
Can acute overdose of metformin lead to lactic acidosis?
Wills, B. K., Bryant, S. M., Buckley, P., & Seo, B. (2010) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2009.04.012 · Cited by 62
Metformin Therapy in Diabetes: The Role of Cardioprotection
Messaoudi, S. E., Rongen, G. A. P. J. M., & Riksen, N. P. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0314-z · Cited by 62
Metformin Stimulates FGF21 Expression in Primary Hepatocytes
Nygaard, E. B., Vienberg, S. G., Ørskov, C., Hansen, H. S., & Andersen, B. (2012) · Experimental Diabetes Research · doi:10.1155/2012/465282 · Cited by 62
Rana, S., Blowers, E. C., & Natarajan, A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401994c · Cited by 63
On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
Penkert, J., Ripperger, T., Schieck, M., Schlegelberger, B., Steinemann, D., & Illig, T. (2016) · Oncotarget · doi:10.18632/oncotarget.11759 · Cited by 64
Inata, Y., Kikuchi, S., Samraj, R. S., Hake, P. W., O’Connor, M., Ledford, J. R., O'Connor, J., Lahni, P. M., Wolfe, V., Piraino, G., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700576r · Cited by 63
Rotroff, D. M., Yee, S. W., Zhou, K., Marvel, S. W., Shah, H., Jack, J. R., Havener, T. M., Hedderson, M. M., Kubo, M., Herman, M. A., et al. (2018) · Diabetes · doi:10.2337/db17-1164 · Cited by 64
Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells
Loubière, C., Goiran, T., Laurent, K., Djabari, Z., Tanti, J., & Bost, F. (2015) · Oncotarget · doi:10.18632/oncotarget.3404 · Cited by 62
Alomari, S., Zhang, I., Hernandez, A., Kraft, C. N., Raj, D., Kedda, J. N., & Tyler, B. (2021) · Biomolecules · doi:10.3390/biom11121870 · Cited by 61
Barreto‐Torres, G., Hernández, J. S., Jang, S., Rodríguez‐Muñoz, A., Torres‐Ramos, C. A., Basnakian, A. G., & Javadov, S. A. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00414.2014 · Cited by 62
Barreto‐Torres, G., Parodi‐Rullán, R. M., & Javadov, S. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13067694 · Cited by 61
Speirs, C., Williams, J. J. L., Riches‐Suman, K., Salt, I. P., & Palmer, T. M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.10.001 · Cited by 61
Metformin-induced anticancer activities: recent insights
Safe, S. H., Nair, V., & Karki, K. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0271 · Cited by 62
Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis
Seliger, C., Genbrugge, E., Gorlia, T., Chinot, O. L., Stupp, R., Nabors, B., Weller, M., Hau, P., & for the EORTC Brain Tumor Group (2019) · International Journal of Cancer · doi:10.1002/ijc.32337 · Cited by 61
Metformin Alters Locomotor and Cognitive Function and Brain Metabolism in Normoglycemic Mice
Li, W., Chaudhari, K., Shetty, R. A., Winters, A., Gao, X., Hu, Z., Ge, W., Sumien, N., Forster, M. J., Liu, R., et al. (2019) · Aging and Disease · doi:10.14336/ad.2019.0120 · Cited by 61
Pharmacology of metformin – An update
Glossmann, H. H., & Lutz, O. M. D. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172782 · Cited by 62
Metadata
- Authors
- OWEN, M. R., DORAN, E., & HALESTRAP, A. P.
- Affiliations
- University of Bristol (GB)
- ORCID
- HALESTRAP, Andrew P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-06-07
- Volume
- 348
- Issue
- 3
- Pages
- 607-614
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221104
- OpenAlex
- W1995069275
- Cited by
- 2,157
- References
- 35
- Citations by year
- 2026: 64 · 2025: 78 · 2024: 92 · 2023: 125 · 2022: 127 · 2021: 157 · 2020: 163 · 2019: 144 · 2018: 142 · 2017: 144 · 2016: 139 · 2015: 126 · 2014: 135 · 2013: 112 · 2012: 75
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWE Research Repository (UWE Bristol) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, mitochondrial complex I inhibition, mitochondrial respiratory chain, type 2 diabetes, gluconeogenesis, hepatocytes, mitochondrial membrane potential, lactic acidosis, glucose utilization, mechanism of action
- MeSH terms
- Animals, Electron Transport, Gluconeogenesis, Hypoglycemic Agents, Liver, Male, Metformin, Mitochondria, NADH, NADPH Oxidoreductases, Submitochondrial Particles, Tumor Cells, Cultured, Signal Transduction, Rats, Wistar, Electron Transport Complex I, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
